title: Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation.
abstract: Cells of the neural retina in the chick embryo undergo several waves of apoptosis during development, including peaks at approximately embryonic day (ED) 7 and 12. Prominent among the cells involved in these phases of cell death are the retinal ganglion cells (RGCs). We have previously shown that growth hormone (GH) is expressed in the neural retina, and particularly, in the RGCs. Here we study the ability of GH to rescue retinal cells from apoptosis, both in vitro and in vivo. When retinas from embryos at ED 6-8 are explanted on collagen gels, the application of recombinant GH, at 10(-6)m, significantly reduced the incidence of apoptotic cells in the cultures as judged by terminal deoxynucleotide transferase-mediated dUTP-biotin nick end labelling (TUNEL). GH was delivered to neural retinas in ovo, by microinjection into the eye cup at ED 2. When these embryos were examined at ED 6-8, no reduction in cell death was observed below the normal low control levels. However, when antibodies to GH were microinjected, the incidence of cell death increased significantly at ED 6, providing evidence that in vivo immunoneutralization of endogenous GH results in triggering of apoptotic signaling pathways. Evidence that RGCs are a particular target of this neuroprotective effect of GH was provided by examination of cultures enriched for RGCs by immunopanning. In serum-free culture, RGCs, identified by anti-Islet 1 immunolabelling, were found to be susceptible to the effect of GH immunoneutralization, which approximately quadrupled the incidence of apoptosis in the cultures. We propose that GH is a naturally occurring autocrine and/or paracrine neuroprotective agent in the developing retina which is involved in the regulation of retinal cell numbers during early embryogenesis.
authors.affiliation: Department of Physiology, University of Alberta, 755 Medical Sciences Building, Edmonton, Alta, Canada T6G 2H7. esmond.sanders@ualberta.ca
authors.forename: Esmond J
authors.initials: EJ
authors.lastname: Sanders
authors.forename: Eve
authors.initials: E
authors.lastname: Parker
authors.forename: Carlos
authors.initials: C
authors.lastname: Arámburo
authors.forename: Steve
authors.initials: S
authors.lastname: Harvey
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000494:pharmacology / Q000502:physiology*; D015153:Blotting, Western; D002645:Chickens; D004627:Embryonic Induction / Q000502:physiology*; D013006:Growth Hormone / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D020287:In Situ Nick-End Labeling; D018613:Microscopy, Confocal; D012160:Retina / Q000196:embryology*; D012165:Retinal Ganglion Cells / Q000166:cytology / Q000378:metabolism*; D046509:Tissue Culture Techniques
chemical_list: D000911:Antibodies, Monoclonal; D051017:Apoptosis Regulatory Proteins; D013006:Growth Hormone